✦ LIBER ✦

Primary ovarian insufficiency: a more accurate term for premature ovarian failure

✍ Scribed by Corrine K. Welt

Book ID: 108703956
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 156 KB
Volume: 68
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2007.03073.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A susceptibility gene for premature ovar

A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28

✍ Rossetti, Francesca; Rizzolio, Flavio; Pramparo, Tiziano; Sala, Cinzia; Bione, S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB

Primary ovarian failure and small for ge

Primary ovarian failure and small for gestational age: A previously unrecognised association

✍ Sarah Ehtisham; Margaret Zacharin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Novel NOBOX loss-of-function mutations a

Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort

✍ Justine Bouilly; Anne Bachelot; Isabelle Broutin; Philippe Touraine; Nadine Bina 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

Primary ovarian insufficiency (POI) is a disorder associated with female infertility, which affects approximately 1% of women under 40 years of age. A genetic component has been suggested as one possible cause of the majority of cases of nonsyndromic forms. Newborn Ovary Homeobox (NOBOX) is an ovary

Epigenetic control of the critical regio

Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: a hypothesis

✍ Flavio Rizzolio; Cinzia Sala; Simone Alboresi; Silvia Bione; Serena Gilli; Mara 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 516 KB

Use of a gonadotropin-releasing hormone

Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

✍ Emily C. Somers; Wendy Marder; Gregory M. Christman; Vladimir Ognenovski; W. Jos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study was performed to evaluate the effectiveness

Fragile X premutation is a significant r

Fragile X premutation is a significant risk factor for premature ovarian failure: The international collaborative POF in fragile X study?preliminary data

✍ Allingham-Hawkins, Diane J.; Babul-Hirji, Riyana; Chitayat, David; Holden, Jeane 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

The preliminary results of an international collaborative study examining premature menopause in fragile X carriers are presented. A total of 760 women from fragile X families was surveyed about their fragile X carrier status and their menstrual and reproductive histories. Among the subjects, 395 ca